Integrated Wealth Concepts’s Acumen Pharmaceuticals ABOS Stock Holding History

Integrated Wealth Concepts’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24K	Buy	+10,179	New	+$26K	﹤0.01%	2253
2025 Q4	–	Sell	-10,179	Closed	-$17.4K	–	1604
2025 Q3	$17.4K	Sell	10,179 -247	-2%	-$342	﹤0.01%	1971
2025 Q2	$12.1K	Sell	10,426 -4,793	-31%	-$5.15K	﹤0.01%	1894
2025 Q1	$16.7K	Buy	15,219 +5,119	+51%	+$7.31K	﹤0.01%	1721
2024 Q4	$17.4K	Buy	+10,100	New	+$24.3K	﹤0.01%	1706
2024 Q2	–	Sell	-10,100	Closed	-$40.9K	–	1644
2024 Q1	$40.9K	Sell	10,100 -4,500	-31%	-$17K	﹤0.01%	1621
2023 Q4	$56.1K	Buy	14,600 +1,000	+7%	+$2.97K	﹤0.01%	1555
2023 Q3	$56.4K	Buy	+13,600	New	+$84K	﹤0.01%	1508

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Integrated Wealth Concepts's ABOS Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in Acumen Pharmaceuticals (ABOS) in Q1 2026: 10,179 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #2253 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in ABOS as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in ABOS in Q3 2023 and has held it in 8 quarters since. The position peaked at $56.4K in Q3 2023. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

Integrated Wealth Concepts held 10,179 shares of Acumen Pharmaceuticals worth $24K as of Q1 2026.
Acumen Pharmaceuticals was a new Integrated Wealth Concepts position in Q1 2026.
Acumen Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2253 holding.
Integrated Wealth Concepts first reported a position in Acumen Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
Integrated Wealth Concepts's Acumen Pharmaceuticals position peaked at $56.4K in Q3 2023.
84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.